The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: REMASTer: REcurrent Brain Metastases After SRS Trial
Official Title: REMASTer: REcurrent Brain Metastases After SRS Trial
Study ID: NCT05124912
Brief Summary: Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Duke University Hospital, Durham, North Carolina, United States
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Kettering Health, Kettering, Ohio, United States